Xcout IntelGemphire
Gemphire Therapeutics was a U.S. clinical-stage biopharmaceutical company developing gemcabene, an investigational lipid-modulating drug intended to treat dyslipidemia and…
The full profile of Gemphire
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Gemphire →Already a subscriber? Sign in
Xcout Intel tracks Gemphire continuously — this profile deepens as new filings, funding, people and hiring data arrive.